Dr. Torsten Neuefeind

Chief Executive Officer and Co-founder

As one of the company founders, Dr. Neuefeind became the CEO in 1998 following the writing of an award winning (McKinsey & Co) business plan for Proteros. He gained industrial and academic research experience in the field of protein structure analysis at Bayer AG and the Max-Planck-Institutes for Biochemistry, Martinsried. Dr. Neuefeind received a Ph.D. in the area of X-ray protein crystallography on drug targets under the supervision of Prof. Robert Huber. Dr. Neuefeind studied chemistry at the Universities of Marburg and Freiburg, Germany.